Elisabeth Livingstone
German Cancer Research Center(DE)Düsseldorf University Hospital(DE)National Center for Tumor Diseases(DE)Essen University Hospital(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,066 cited
- → Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma(2015)288 cited
- → Immunotherapy in melanoma: Recent advances and future directions(2016)270 cited
- → TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma(2014)254 cited
- → Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial(2020)240 cited
- → Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition(2012)